PERINI, PIETRO
PERINI, PIETRO
DIPARTIMENTO DI MEDICINA CLINICA E PREVENZIONE (attivo dal 10/07/2006 al 30/09/2012)
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib
2015 Redaelli, S; Perini, P; Ceccon, M; Piazza, R; Rigolio, R; Mauri, M; Boschelli, F; Giannoudis, A; GAMBACORTI PASSERINI, C
In Vitro and in Vivo Characterization of Bosutinib as Substrate of the Pglycoprotein Efflux Transporter
2014 Redaelli, S; Perini, P; Ceccon, M; Piazza, R; Rigolio, R; Boschelli, F; Giannoudis, A; GAMBACORTI PASSERINI, C
Uptake/ efflux molecular mechanisms responsible for bosutinib multidrug resistance
2011 Perini, P
Reply to P. Laneuville et al
2010 Gambacorti-Passerini, C; Piazza, R; Perini, P; Rostagno, R; Redaelli, S
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib
2010 Redaelli, S; Boschelli, F; Perini, P; Pirola, A; Viltadi, M; GAMBACORTI PASSERINI, C
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants
2009 Redaelli, S; Piazza, R; Rostagno, R; Magistroni, V; Perini, P; Marega, M; GAMBACORTI PASSERINI, C; Boschelli, F
Bosutinib is a Substrate of the ABC Efflux Transporter P-Glycoprotein
2009 Perini, P; Redaelli, S; Piazza, R; Viltadi, M; Boschelli, F; GAMBACORTI PASSERINI, C
Proteomic profiling of cervical and lumbar spinal cord reveals potential protective mechanisms in the Wobbler mouse, a model of motor neuron degeneration
2009 Bastone, A; Fumagalli, E; Bigini, P; Perini, P; Bernardinello, D; Cagnotto, A; Mereghetti, I; Curti, D; Salmona, M; Mennini, T
Determination of the Activity Profile of Bosutinib, Dasatinib and Nilotinib against 18 Imatinib Resistant Bcr/Abl Mutants
2008 Redaelli, S; Piazza, R; Rostagno, R; Sassone, M; Magistroni, V; Perini, P; Marega, M; Boschelli, F; GAMBACORTI PASSERINI, C